Wat wij doen

Nieuws

VACSERA and Bilthoven Biologicals sign for polio vaccine manufacturing technology

Bilthoven October 24th 2024 - A significant milestone for Egypt’s self-sufficiency on polio vaccines was reached on October 21st with the signing of the tech transfer agreement between VACSERA and Bilthoven Biologicals.
Lees verder
Nieuws

SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY® - a novel Tuberculosis Skin Test
Nieuws

Bilthoven Biologicals and Tonix Pharmaceuticals collaborate on advancing viral vector based Mpox Vaccine
Binnenkijken bij Nieuws

‘BBio ligt op schema en bereidt zich precies voor zoals de EU het EU Pandemic Preparedness-programma heeft bedacht’. 
Meer artikelen